The article says to watch for severe nausea, vomiting, persistent diarrhea, abdominal pain, or signs of dehydration while both medications are in use
Changes in glucagon levels with semaglutide treatment (AUC 512mmol ) were significantly lower compared with placebo (0.87 [0.82, 0.93]
Theres definitely a mechanism behind this, says Kunal Shah, MD, an assistant professor in the division of endocrinology at the Rutgers Robert Wood Johnson Medical Center
But if it becomes a pattern, the medication may stop working as effectively
Therefore, the safety profile of microdosing GLP 1 drugs is still unknown
Freezing compromises the molecule